# Trade Mark Journal No.2026/017 24 April 2026

## UK00004367571 1 April 2026 (5,9,42,44)

VIVARUS

International priority date claimed: 13 March 2026 (European Union Intellectual Property Office (EUIPO)) (019330065)

Class 5
  Pharmaceutical preparations for human use; Medicines for human purposes; Biological preparations for medical purposes; Medicinal healthcare preparations; Biochemical preparations for medical use; Pharmaceutical preparations.
Class 9
  Computer software for use in medical decision support systems; Artificial intelligence software for analysis; Artificial intelligence software for healthcare; Artificial intelligence and machine learning software; Software as a medical device [SaMD], downloadable; Health monitoring software; Computer software relating to the medical field; Risk detection software; Threat detection software; Software for remote diagnostics.
Class 42
  Software as a service [SaaS] featuring computer software platforms for artificial intelligence; Platform as a service [PaaS]; Providing temporary use of non-downloadable software; Medical research in the field of rare diseases; Research in the field of artificial intelligence technology; Software design and development; Design and development of medical diagnostic apparatus; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research relating to pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Scientific research for medical purposes; Development and testing of computing methods, algorithms and software.
Class 44
  Health-care services; Medical care and analysis services relating to patient treatment; Medical analysis services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Services for the provision of medical care information; Medical diagnostic services; Providing information relating to medical services; Providing medical information in the healthcare sector; Providing medical information; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis services relating to the treatment of patients; Performing diagnosis of diseases; Advisory services relating to medical services; Medical analysis services relating to the treatment of persons; Consultancy services relating to health care.

Vivarus Biopharma GmbH

Representative: Fillun & Decketts Ltd.